Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,946
Total Claims
$1.2M
Drug Cost
572
Beneficiaries
$2,090
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-52%
Opioid rate vs peers
1.2% vs 2.6% avg
+96%
Cost per patient vs peers
$2,090 vs $1,068 avg
+26%
Brand preference vs peers
11.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.2%
Opioid Rate
110
Opioid Claims
$1,187
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,001 claims · $987K
Generic: 7,856 claims · $202K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 50 | $123K |
| Apixaban | 83 | $112K |
| Semaglutide | 45 | $98K |
| Empagliflozin | 47 | $84K |
| Insulin Aspart | 24 | $72K |
| Fluticasone/Umeclidin/Vilanter | 75 | $63K |
| Insulin Lispro | 28 | $41K |
| Empagliflozin/Metformin Hcl | 30 | $33K |
| Insulin Detemir | 14 | $17K |
| Insulin Degludec | 17 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 12 | $13K |
| Atorvastatin Calcium | 726 | $13K |
| Sacubitril/Valsartan | 13 | $10K |
| Tiotropium Bromide | 14 | $9,412 |
| Fluticasone Propionate | 14 | $9,386 |
Prescribing Profile
Patient Profile
73
Avg Age
66%
Female
0.94
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About